AAL

Vaccine Sector Rally Over for These 2 Stocks

Both stocks are still eyeing impressive year-to-date wins, however

Digital Content Manager
Dec 29, 2021 at 9:36 AM
facebook X logo linkedin


Vaccine stocks have been in a recent downfall, and getting hit particularly hard are Moderna Inc (NASDAQ:MRNA) and BioNTech SE (NASDAQ:BNTX). At last check, MRNA was down 1.3% to trade at $238.36, while BioNTech stock was last seen down 3% at $234.20. 

Both stocks are extending lengthy losing streaks. Starting with BNTX, the security is pacing for its seventh-daily drop, marking its longest slump since late August. The recent drop has put the stock back below long-term support at its 200-day moving average, though the shares look ready to ring in the new year with an over 196% lead for 2021. 

Moderna stock hasn't fared much better, as its also headed for its seventh-straight loss, which would be its longest daily lose streak since June 2019. Similarly to BNTX, MRNA still sports an impressive year-to-date lead of 131%, though today's dip could put the stock south of recent support at the $240 area. 

Analysts seem to have predicted this selloff, as the brokerage bunch has been hesitant on both stocks. Currently, all but one of the seven covering BNTX call it a "hold." Meanwhile, Moderna stock has enjoyed a slightly better reception, with five "strong buy" ratings to its name, however, the eight others in coverage consider it a "hold" or worse. 

 

Same-Day Trading Power: +227% YTD and Counting  — Get in for $10!

We're celebrating 44 years of helping traders win, and you can now tap into one of our most explosive services — Dynamite Day Trading Signals — for just $10.

This service was built for one thing: capturing intraday gains with precision. 

Access two highly-vetted options trades each week -  Complete with defined entries, exits, and a clear plan for same-day profits.

👉 Click Here to Learn More and Position Yourself to Take Action When the Next Alert Hits.